ISRG - Intuitive Surgical, Inc.
| Previous Close | 497.83 |
| Open | 501.50 |
| Bid | 502.84 x 1200 |
| Ask | 503.37 x 900 |
| Day's Range | 500.00 - 504.48 |
| 52 Week Range | 430.24 - 589.32 |
| Volume | 150,185 |
| Avg. Volume | 680,473 |
| Market Cap | 58.143B |
| Beta (3Y Monthly) | 1.27 |
| PE Ratio (TTM) | 49.81 |
| EPS (TTM) | 10.13 |
| Earnings Date | Oct 16, 2019 - Oct 21, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 584.20 |
- Zacks
Here's Why You Should Add Stryker (SYK) to Your Portfolio
Stryker (SYK) gains from core segments in the second quarter of 2019.
- Investor's Business Daily
When To Buy Growth Stocks: Some Leaders Can Still Run After Forming Late Stage Bases
While Intuitive Surgical showed why late-stage bases are an excellent topping signal, it also proves how some great companies can eventually lead again.
- Zacks
Medtronic (MDT) Beats on Q1 Earnings, Ups FY20 EPS Guidance
Medtronic (MDT) displays improved performances at CER, banking on growth across all major segmental businesses as well as geographies.
- Zacks
Here's Why You Should Snap Up Baxter International (BAX) Now
For 2019, Baxter (BAX) expects adjusted earnings per share within $3.34-$3.40.
- Zacks
Accuray (ARAY) Reports Loss in Q4, Revenues Beat Estimates
Accuray (ARAY) expects fiscal 2020 revenues to be impacted by China tariffs.
- Motley Fool
5 Top Cancer-Fighting Stocks to Buy Now
Each of these healthcare companies takes a different approach to fighting cancer, but all have what it takes to be long-term winners in your portfolio.
- GuruFocus.com
Philippe Laffont's Top 6 Buys in the 2nd Quarter
Former Tiger Cub’s top buys include ride-hailing IPO and remote conferencing IPO Continue reading...
- Zacks
Glaukos (GKOS) Q2 Loss Wider Than Estimates, '19 View Raised
Glaukos (GKOS) raises 2019 revenues view; optimistic about Avedro buyout.
- Motley Fool
3 High-Growth Stocks to Secure Your Financial Future
These fast-growing companies just keep getting better with each passing year.
- Zacks
Nevro (NVRO) Q2 Loss Wider Than Expected, Revenues Down Y/Y
Nevro (NVRO) sees dismal segmental performance in Q2.
- Zacks
Inogen (INGN) Q2 Earnings Miss Estimates, 2019 View Lowered
Inogen (INGN) gains from international revenues in Q2; slashes 2019 guidance.
- Zacks
Pacific Biosciences (PACB) Beats on Q2 Earnings & Revenues
Pacific Biosciences (PACB) Q2 results gain from higher revenues and strong segmental performance. Contraction in gross margin remains a woe.
- Zacks
Allscripts (MDRX) Q2 Earnings Top Estimates, Revenues Lag
Allscripts (MDRX) second-quarter results gain from growth in bookings and solid show by client services segment. Contraction in operating margin remains a woe.
- Zacks
Tandem (TNDM) Q2 Loss Narrower Than Expected, Sales Top Mark
Tandem Diabetes' (TNDM) t:slim X2 Insulin pump's strength in domestic sales along with expansion in international markets during Q2 is encouraging.
- Motley Fool
Here's Why TransEnterix Fell Hard on Thursday
The Senhance Surgical System's launch isn't progressing nearly as well as investors had hoped.
- Zacks
Adidas Slips, Lyft Climbs, Uber Earnings & Why Intuitive Surgical Stock is a Strong Buy | Free Lunch
On today's episode of Free Lunch here at Zacks, Associate Stock Strategist Ben Rains offers a quick global economic update. The episode also dives into Adidas (ADDYY), Lyft (LYFT), and Uber (UBER) earnings, and more...
- Zacks
Cardinal Health (CAH) Q4 Earnings and Revenues Top Estimates
Cardinal Health (CAH) Q4 results benefit from strong performance by Pharmaceutical segment and higher revenues. However, contraction in gross margin remains a concern.
- Zacks
LHC Group (LHCG) Q2 Earnings Beat Estimates, Revenues Miss
LHC Group (LHCG) second-quarter results benefit from home health and hospice admissions and higher revenues.
- Zacks
OPKO Health (OPK) Q2 Earnings and Revenues Beat Estimates
OPKO Health (OPK) gains from RAYALDEE prescriptions in Q2.
- Zacks
Wright Medical (WMGI) Earnings Beat in Q2, Guidance Slashed
Wright Medical (WMGI) gains from Upper and Lower Extremities units in Q2; slashes 2019 view.
- Zacks
Cardiovascular Systems (CSII) Earnings Match Estimates in Q4
We are upbeat about the year-over-year uptick in Coronary and peripheral device revenues within Cardiovascular Systems' (CSII) domestic market.
- Zacks
CVS Health (CVS) Beats on Q2 Earnings, Raises '19 Guidance
CVS Health's (CVS) second-quarter top-line growth in Pharmacy Services segment is backed by an uptick in specialty services.
- Zacks
Avanos (AVNS) Q2 Earnings Beat Estimates, Revenues Miss
Avanos (AVNS) second-quarter results benefit from higher revenues, strong segmental performance and expansion in margins.
- Zacks
AMN Healthcare (AMN) Q2 Earnings and Revenues Top Estimates
AMN Healthcare (AMN) issues upbeat revenue guidance for the third quarter of 2019.
